Pancreatectomy

• 

  Subject Areas on Research

  • A selective approach to resection of cystic lesions of the pancreas: results from 539 consecutive patients. 
  • A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. 
  • A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma. 
  • ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer. 
  • Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma. 
  • Adjuvant therapy for pancreatic cancer: an evolving paradigm. 
  • Adjuvant therapy for pancreatic cancer: current status and future directions. 
  • Advances in the management of pancreatic cystic neoplasms. 
  • Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. 
  • Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy. 
  • Assessing post-discharge costs of hepatopancreatic surgery: an evaluation of Medicare expenditure. 
  • Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. 
  • Association of Hospital Market Concentration With Costs of Complex Hepatopancreaticobiliary Surgery. 
  • Chemical pancreatectomy: an unconventional approach to preventing autodigestion in pancreatitis. 
  • Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection. 
  • Chylous ascites. 
  • Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer: A Review. 
  • Clinical significance of bacterial cultures from 28 autologous islet cell transplant solutions. 
  • Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review. 
  • Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. 
  • Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. 
  • Cutaneous Metastasis of a Mucoepidermoid Carcinoma of the Pancreas: First Reported Case. 
  • Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. 
  • Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. 
  • Defining quality for distal pancreatectomy: does the laparoscopic approach protect patients from poor quality outcomes? 
  • Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. 
  • Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. 
  • Distal pancreatectomy for isolated metastasis of endometrial carcinoma to the pancreas. 
  • Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches. 
  • Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? 
  • Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. 
  • Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. 
  • Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. 
  • Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals. 
  • Experimental diabetes in cats induced by partial pancreatectomy alone or combined with local injection of alloxan. 
  • Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. 
  • Extended resection for pancreatic adenocarcinoma. 
  • Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. 
  • Factors regulating islet regeneration in the post-insulinoma NEDH rat. 
  • Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression. 
  • Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. 
  • GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. 
  • Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial. 
  • Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. 
  • Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. 
  • How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? 
  • Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase. 
  • Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients. 
  • Identification of patients at high risk for post-discharge venous thromboembolism after hepato-pancreato-biliary surgery: which patients benefit from extended thromboprophylaxis? 
  • Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. 
  • Impact of minimally invasive vs. open distal pancreatectomy on use of adjuvant chemoradiation for pancreatic adenocarcinoma. 
  • Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy? 
  • Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance? 
  • Increased nonenzymatically glycosylated proteins in the vitreous humor of diabetic animals. 
  • Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma. 
  • Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. 
  • Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation. 
  • Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. 
  • Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? 
  • Intraoperative fluid management and complications following pancreatectomy. 
  • Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. 
  • Islet-like cell clusters: viability, cell types, and subretinal transplantation in pancreatectomized cats. 
  • Laparoscopic distal pancreatectomy with splenic preservation. 
  • Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. 
  • Lending a hand for laparoscopic distal pancreatectomy: the optimal approach? 
  • Liver transplantation in a patient with primary sclerosing cholangitis suffering from lipomatous pseudohypertrophy of the pancreas. 
  • Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma. 
  • Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. 
  • Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. 
  • Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. 
  • Management of blunt pancreatic trauma in children: Review of the National Trauma Data Bank. 
  • Management of locally advanced adenocarcinoma of the pancreas. 
  • Metabolic syndrome and in-hospital outcomes among pancreatic cancer patients. 
  • Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer. 
  • Minimally Invasive Distal Pancreatectomy for Cancer: Short-Term Oncologic Outcomes in 1,733 Patients. 
  • Minimally invasive distal pancreatectomy. 
  • Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. 
  • Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. 
  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. 
  • Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. 
  • New developments in geriatric surgery. 
  • Novel Preoperative Patient-centered Surgical Wellness Program Impacts Length of Stay Following Pancreatectomy. 
  • Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. 
  • Operative resection is currently overutilized for cystic lesions of the pancreas. 
  • Operative vs nonoperative management for blunt pancreatic transection in children: multi-institutional outcomes. 
  • Outcomes after Pancreatectomy with Routine Pasireotide Use. 
  • Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. 
  • Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes. 
  • Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors. 
  • Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. 
  • Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force. 
  • Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. 
  • Pancreatitis complicated by gland necrosis: evolution of findings on contrast-enhanced CT. 
  • Pancreatoblastoma in a teenage patient. 
  • Pasireotide for postoperative pancreatic fistula. 
  • Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. 
  • Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. 
  • Postoperative prognosis prediction of pancreatic cancer with seven microRNAs. 
  • Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. 
  • Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. 
  • Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. 
  • Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. 
  • Primary sarcomas of the pancreas: A review of 253 patients from the National Cancer Data Base. 
  • Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN). 
  • Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy. 
  • Readmission after pancreatic resection: causes and causality pattern. 
  • Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis. 
  • Reduction of basement membrane thickening in diabetic cat retina by sulindac. 
  • Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery. 
  • Reply to Letter: "Operative Drainage Following Pancreatic Resections: We Need More Evidence". 
  • Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. 
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. 
  • Risk factors for pancreatic leak after distal pancreatectomy. 
  • Robotic-assisted minimally invasive central pancreatectomy: technique and outcomes. 
  • Routine intensive care unit admission among patients undergoing major pancreatic surgery for cancer: No effect on failure to rescue. 
  • Sclerosing mesenteritis involving the pancreas: a mimicker of pancreatic cancer. 
  • Should all branch-duct intraductal papillary mucinous neoplasms be resected? 
  • Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. 
  • Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center. 
  • Specificity of procedure volume and in-hospital mortality association. 
  • Surgical management of necrotizing pancreatitis: an overview. 
  • Surgical management of pancreatic necrosis: A practice management guideline from the Eastern Association for the Surgery of Trauma. 
  • Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. 
  • Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. 
  • Synchronous Hemihepatectomy With Pancreatectomy Through Application of Associated Liver Partition and Portal Vein Ligation for a Metastatic Gastrinoma. 
  • The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial. 
  • The Dilemma of the Dilated Main Pancreatic Duct in the Distal Pancreatic Remnant After Proximal Pancreatectomy for IPMN. 
  • The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis. 
  • The Role of Surgery for Pancreatic Neuroendocrine Tumors. 
  • The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. 
  • The management of cystic lesions of the pancreas. 
  • The relationship of hospital market concentration, costs, and quality for major surgical procedures. 
  • The role of clinical care pathways: an experience with distal pancreatectomy. 
  • The use of pancreatic ductoscopy in the operative management of benign and malignant pancreatic disorders. 
  • Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. 
  • Travel distance affects rates and reasons for inpatient visits after pancreatectomy. 
  • Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. 
  • Trends in racial disparities in pancreatic cancer surgery. 
  • Underutilization of surgical resection in patients with pancreatic acinar cell carcinoma. 
  • Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance? 
• 

  Keywords of People

  • Abbruzzese, James, D. C. I. Distinguished Professor of Medical Oncology, Medicine, Medical Oncology
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics